Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality

BMC Urology

Table 3 **Frequency of treatments* for various complications, according to age, among men with newly managed prostate cancer in 2009, still alive after two years**

	40-49	50-54	55-59	60-64	65-69	70-74	75-79	80-84	≥85	All ages
Complications	414	1,433	3,727	6,782	6,792	7,033	5,554	3,106	1,893	36,734
	%	%	%	%	%	%	%	%	%	%
Erectile dysfunction	34.1	46.9	43.9	37.1	27.6	11.8	2.1	0.5	0.1	21.2
Intracavernous injection	33.8	46.7	43.8	37.0	27.5	11.7	2.0	0.4	0.1	21.1
Penile prosthesis	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1
Urinary disorders	14.0	20.4	20.5	19.4	21.8	19.5	17.1	14.6	14.4	18.9
Drug treatment	10.6	15.6	16.4	14.7	17.1	15.9	14.5	11.6	9.3	15.0
External devices	3.9	6.1	5.6	5.8	6.2	4.8	2.6	2.8	4.2	4.8
Surgical procedure	1.0	1.0	1.3	1.4	1.6	1.2	0.4	0.1	0.0	1.0
Clot removal
Surgical procedure	1.2	1.4	1.0	1.3	1.0	1.3	1.4	1.9	2.3	1.4
Urethral stricture
Surgical procedure	1.4	1.5	1.4	1.5	2.0	2.4	2.0	2.0	2.6	1.9
Bladder neck stenosis
Surgical procedure	1.4	2.2	1.7	1.8	1.9	2.0	1.8	1.3	1.2	1.8
Radiation-induced inflammation
Hospitalisation	0.0	0.6	0.5	0.6	0.9	1.4	2.0	0.5	0.1	1.0
Acute urinary retention
Surgical procedure	5.1	3.8	5.4	7.5	8.6	12.6	17.2	20.6	19.4	11.5
Urethral or rectal fistula
Hospitalisation	0.7	0.4	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.2
None	55.1	40.5	40.5	45.2	49.4	60.0	65.4	66.4	64.3	54.1
Drug treatment
Antidepressants	14.5	15.6	12.4	9.2	9.4	9.3	11.6	15.9	18.8	11.3
Anxiolytics	19.3	19.0	17.2	15.0	15.4	17.0	18.2	21.7	23.9	17.4

*Hospitalisation: primary diagnosis, surgical treatment: presence of a specific surgical procedure code, external devices and medication: reimbursement codes.

ISSN: 1471-2490